These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18270495

  • 1. The mTOR inhibitor everolimus attenuates the time course of chronic anti-Thy1 nephritis in the rat.
    Wittmann S, Daniel C, Braun A, Vogelbacher R, Shimizu F, Kawachi H, Hugo C.
    Nephron Exp Nephrol; 2008; 108(2):e45-56. PubMed ID: 18270495
    [Abstract] [Full Text] [Related]

  • 2. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.
    Transplantation; 2007 Dec 15; 84(11):1492-9. PubMed ID: 18091526
    [Abstract] [Full Text] [Related]

  • 3. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K, Daniel C, Schöcklmann H, Endlich KH, Kerjaschki D, Johnson RJ, Hugo C.
    Nephrol Dial Transplant; 2006 Oct 15; 21(10):2724-35. PubMed ID: 16861242
    [Abstract] [Full Text] [Related]

  • 4. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C, Ziswiler R, Frey B, Pfister M, Marti HP.
    Exp Nephrol; 2000 Oct 15; 8(1):52-62. PubMed ID: 10644883
    [Abstract] [Full Text] [Related]

  • 5. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S, Wang-Rosenke Y, Scholl V, Binder E, Loof T, Khadzhynov D, Kawachi H, Shimizu F, Diekmann F, Budde K, Neumayer HH, Peters H.
    Am J Physiol Renal Physiol; 2008 Feb 15; 294(2):F440-9. PubMed ID: 18094032
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.
    Daniel C, Renders L, Amann K, Schulze-Lohoff E, Hauser IA, Hugo C.
    Am J Transplant; 2005 Dec 15; 5(12):2849-61. PubMed ID: 16302997
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y, Krämer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H.
    Kidney Int; 2005 Jul 15; 68(1):47-61. PubMed ID: 15954895
    [Abstract] [Full Text] [Related]

  • 8. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, Tsai TJ.
    Kidney Int; 1999 Sep 15; 56(3):932-43. PubMed ID: 10469361
    [Abstract] [Full Text] [Related]

  • 9. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
    Chen YM, Hu-Tsai MI, Lin SL, Tsai TJ, Hsieh BS.
    Nephrol Dial Transplant; 2003 Dec 15; 18(12):2505-14. PubMed ID: 14605272
    [Abstract] [Full Text] [Related]

  • 10. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
    Takazawa Y, Maeshima Y, Kitayama H, Yamamoto Y, Kawachi H, Shimizu F, Matsui H, Sugiyama H, Yamasaki Y, Makino H.
    Kidney Int; 2005 Aug 15; 68(2):704-22. PubMed ID: 16014048
    [Abstract] [Full Text] [Related]

  • 11. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
    Peters H, Daig U, Martini S, Rückert M, Schäper F, Liefeldt L, Krämer S, Neumayer HH.
    Kidney Int; 2003 Aug 15; 64(2):509-18. PubMed ID: 12846746
    [Abstract] [Full Text] [Related]

  • 12. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H, Wang Y, Loof T, Martini S, Kron S, Krämer S, Neumayer HH.
    Kidney Int; 2004 Dec 15; 66(6):2224-36. PubMed ID: 15569311
    [Abstract] [Full Text] [Related]

  • 13. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis.
    Tanaka T, Matsumoto M, Inagi R, Miyata T, Kojima I, Ohse T, Fujita T, Nangaku M.
    Kidney Int; 2005 Dec 15; 68(6):2714-25. PubMed ID: 16316346
    [Abstract] [Full Text] [Related]

  • 14. Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model.
    Kurdián M, Herrero-Fresneda I, Lloberas N, Gimenez-Bonafe P, Coria V, Grande MT, Boggia J, Malacrida L, Torras J, Arévalo MA, González-Martínez F, López-Novoa JM, Grinyó J, Noboa O.
    PLoS One; 2012 Dec 15; 7(3):e32516. PubMed ID: 22427849
    [Abstract] [Full Text] [Related]

  • 15. Effect of Everolimus versus Bone Marrow-Derived Stem Cells on Glomerular Injury in a Rat Model of Glomerulonephritis: A Preventive, Predictive and Personalized Implication.
    Zedan MM, Mansour AK, Bakr AA, Sobh MA, Khodadadi H, Salles EL, Alhashim A, Baban B, Golubnitschaja O, Elmarakby AA.
    Int J Mol Sci; 2021 Dec 29; 23(1):. PubMed ID: 35008770
    [Abstract] [Full Text] [Related]

  • 16. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
    Chen YM, Chiang WC, Yang Y, Lai CF, Wu KD, Lin SL.
    Mol Med; 2015 Apr 13; 21(1):276-84. PubMed ID: 25879629
    [Abstract] [Full Text] [Related]

  • 17. Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti-Thy1 glomerulonephritis.
    Sakai N, Iseki K, Suzuki S, Mori T, Hagino S, Zhang Y, Yokoya S, Kawasaki Y, Suzuki J, Isome M, Wada I, Homma Y, Suzuki H.
    Pathol Int; 2005 Jan 13; 55(1):19-26. PubMed ID: 15660699
    [Abstract] [Full Text] [Related]

  • 18. Renovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis.
    Wenzel UO, Wolf G, Thaiss F, Helmchen U, Stahl RA.
    Kidney Int; 2000 Sep 13; 58(3):1135-47. PubMed ID: 10972677
    [Abstract] [Full Text] [Related]

  • 19. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
    Hartner A, Schöcklmann H, Pröls F, Müller U, Sterzel RB.
    Kidney Int; 1999 Oct 13; 56(4):1468-80. PubMed ID: 10504498
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
    Hohenstein B, Daniel C, Wagner A, Stasch JP, Hugo C.
    Am J Physiol Renal Physiol; 2005 Apr 13; 288(4):F685-93. PubMed ID: 15561976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.